TG Therapeutics TGTX Q2 2025 earnings
Reported August 4, 2025 · Before market open
Revenue$141.1MMiss by $5.1M
EPS$0.17Miss by $0.15
Revenue estimate$146.3M
EPS estimate$0.32
Next report
Aug 3, 2026 (In 4 days)Revenue estimate$229.8M
EPS estimate$0.31
Financials
Q2 2025Valuation & ratios
Versus estimates
Revenue
Diluted EPS
Ask the moment TG Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did TG Therapeutics report Q2 2025 earnings?
- TG Therapeutics (TGTX) reported Q2 2025 earnings on August 4, 2025 before market open.
- What were TG Therapeutics's Q2 2025 revenue and EPS?
- TG Therapeutics reported revenue of $141.1M and eps of $0.17 for Q2 2025.
- Did TG Therapeutics beat estimates in Q2 2025?
- Revenue missed the consensus estimate of $146.3M by $5.1M. EPS missed the consensus estimate of $0.32 by $0.15.
- How did TG Therapeutics's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 92.1% from $73.5M a year earlier and eps grew 325.0% from $0.04.
- Where can I find TG Therapeutics's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001437749-25-025745) directly on SEC EDGAR. The filing index links above go to sec.gov.